Our Mission
Cell-based technologies are poised to redefine medicine—but immature cells are holding it back. boutIQ solutions is solving this critical bottleneck.
Our proprietary AI/ML platform, HiDiNeu, designs high-performance culture media tailored to specific cell types, accelerating maturation from months to weeks.
We’re accelerating the path to clinic and building the foundation for the next wave of regenerative medicine.
Our Vision
boutIQ is developing the enabling technology to advance the next generation of cell-based applications. By extending our platform across therapeutic and industrial domains—including immunotherapy and cellular agriculture—we aim to drive more effective and scalable biological solutions.
At boutIQ, we don’t just solve one problem - we unlock better biology.
Our Team
Founding Members
Julie Audet, PhD, Peng
CEO & Co-Founder
Expert in Statistical DoE, Bioprocess Analytics & ML-Driven Stem Cell Culture Optimization
Craig Simmons PhD, Peng
COO & Co-Founder
Expert in Cardiovascular Engineering, Regenerative Medicine & Micro-fluidic Vascularized Tissue Models
Neal Callaghan, MD, PhD
CSO & Co-Founder
Developer of boutIQ’s First Cardiac-Specific Media Product & Contributor to Translational Strategy
Researchers
Alice Feng, MASc
Computational Scientist
Leads AI/ML development behind HiDiNeu, designing algorithms to optimize biological systems.
Doris Adao, PhD
Research Scientist
Leads in vivo media development, advancing optimized formulations into preclinical validation.
Heta Lad, PhD
Research Scientist
Leads strategy, partnerships, and media optimization, translating scientific innovation into real-world impact.
Want to meet the team? Get in touch!
At boutIQ solutions Inc, we are transforming how custom cell culture media is developed, using powerful AI to drive faster and smarter biological discovery. We’re excited to explore new horizons together!